These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7022963)
21. The role of HLA typing in clinical kidney transplants: 30 years later. Matas AJ; Najarian JS Clin Transpl; 1993; ():428-30. PubMed ID: 7918175 [No Abstract] [Full Text] [Related]
22. Evidence for a suppressor cell system in human kidney allograft tolerance. Charpentier B; Lang P; Martin B; Fries D Transplant Proc; 1981 Mar; 13(1 Pt 1):90-4. PubMed ID: 6455811 [No Abstract] [Full Text] [Related]
23. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation. Lo A; Stratta RJ; Alloway RR; Hodge EE; Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699 [TBL] [Abstract][Full Text] [Related]
24. [Biological role and the clinical significance of the HLA histocompatibility system]. Zaretskaia IuM Vestn Akad Med Nauk SSSR; 1979; (7):71-6. PubMed ID: 395790 [No Abstract] [Full Text] [Related]
27. Prediction of cadaveric allograft survival based on pretransplant nonspecific immunocompetence. Kerman RH; Floyd M; Van Buren CT; Kahan BD Transplant Proc; 1981 Sep; 13(3):1533-5. PubMed ID: 7029808 [No Abstract] [Full Text] [Related]
28. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
29. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation]. Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425 [TBL] [Abstract][Full Text] [Related]
30. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Opelz G; Döhler B Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803 [TBL] [Abstract][Full Text] [Related]
31. Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting. Christiaans MH; van den Berg-Loonen PM; Nieman FH; Cohen B; Kootstra G; van Hooff JP Transplant Proc; 1993 Feb; 25(1 Pt 2):1685-6. PubMed ID: 8442236 [No Abstract] [Full Text] [Related]
32. Reduction of the center effect by HLA matching. Gjertson DW; Terasaki PI; Cecka JM; Takemoto S Transplant Proc; 1993 Feb; 25(1 Pt 1):215-6. PubMed ID: 8438276 [No Abstract] [Full Text] [Related]
34. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants. Sasaki N; Idica A; Hall B; Terasaki PI Clin Transpl; 2008; ():241-52. PubMed ID: 19711515 [TBL] [Abstract][Full Text] [Related]
35. Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching. Gjertson DW; Takemoto S; Cecka JM; Terasaki PI Transplant Proc; 1995 Feb; 27(1):653-5. PubMed ID: 7879132 [No Abstract] [Full Text] [Related]
36. Graft vs host disease following kidney transplantation using an '0 HLA antigen mismatched' donor. Smith DM; Agura ED; Levy MF; Melton LB; Domiati-Saad R; Klintmalm G Nephrol Dial Transplant; 2006 Sep; 21(9):2656-9. PubMed ID: 16627604 [No Abstract] [Full Text] [Related]
37. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Ozawa M; Terasaki PI; Lee JH; Castro R; Alberu J; Alonso C; Alvarez I; Toledo R; Alvez H; Monterio M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Conca R; Gomez B; Monteon F; Grosse-Wilde H; Heinemann F; Humar I; Kamoun M; Kimball P; Kobayashi T; Kupatawintu P; Leech S; LeFor W; Mehra N; Panigrahi A; Naumova E; Norman D; Piazza A; Poli F; Colombo B; Roy R; Schonemann C; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A Tissue Antigens; 2007 Apr; 69 Suppl 1():174-9. PubMed ID: 17445195 [TBL] [Abstract][Full Text] [Related]
38. High graft survival with spousal and 2-HLA-haplotype mismatched sibling-donor transplants. Terasaki PI; Cecka JM; Gjertson DW Clin Transpl; 1994; ():366-8. PubMed ID: 7547564 [No Abstract] [Full Text] [Related]
39. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody. Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462 [TBL] [Abstract][Full Text] [Related]
40. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses. Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]